Health Care Analysis on Myocardial Revascularization in Patients with Chronic Coronary Artery Disease: The Multicenter REVASK Study: Design and Protocol

Andreas Beckmann; Eva-Maria Bitzer; Mareike Lederle; Peter Ihle; Jochen Walker; Ursula Marshall; Dirk Horenkamp-Sonntag; Steffen Schneider; Uwe Zeymer; for the REVASK Study Group

doi:10.1055/s-0040-1721391

The Thoracic and Cardiovascular Surgeon, Table of Contents

CC BY-NC-ND 4.0 · Thorac Cardiovasc Surg 2021; 69(07): 599-606
DOI: 10.1055/s-0040-1721391

Original Cardiovascular

Health Care Analysis on Myocardial Revascularization in Patients with Chronic Coronary Artery Disease: The Multicenter REVASK Study: Design and Protocol

Andreas Beckmann

¹German Society for Thoracic and Cardiovascular Surgery (GSTCVS), Berlin, Germany

,

Eva-Maria Bitzer

²University of Education, Freiburg, Germany

,

Mareike Lederle

²University of Education, Freiburg, Germany

,

Peter Ihle

³PMV research group, University of Cologne, Cologne, Germany

,

Jochen Walker

⁴Institute for Applied Health Research Berlin GmbH (InGef), Berlin, Germany

,

Ursula Marshall

⁵Barmer, Wuppertal, Germany

,

Dirk Horenkamp-Sonntag

⁶Techniker Krankenkasse, Hamburg, Germany

,

Steffen Schneider

⁷Institut für Herzinfarktforschung Ludwigshafen, Ludwigshafen, Germany

,

Uwe Zeymer

⁷Institut für Herzinfarktforschung Ludwigshafen, Ludwigshafen, Germany

,

for the REVASK Study Group

› Author Affiliations

Abstract

All articles of this category

Abstract

Coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI) are available for revascularization of coronary artery disease (CAD) with the aims to reduce cardiovascular morbidity and mortality and to improve disease-related quality of life in particular. The German National Care Guideline (NVL-cKHK) on chronic CAD recommends the establishment of so-called heart teams for decision making in myocardial revascularization to improve the quality of care. Preferred recommendations for PCI or CABG are given for different patient subgroups depending on patient characteristics, concomitant diseases, and coronary morphology. The myocardial revascularization study (REVASK) is a noninterventional cohort study on care of patients undergoing PCI or CABG based on retrospective statutory health insurance (SHI) routine data, registry data from the German Cardiac Society (DGK) resp., the German Society for Thoracic and Cardiovascular Surgery (DGTHG), combined with prospective primary data collection from health care providers and patients. The primary goal is to investigate whether and to which extent heart teams, consisting of cardiologists and cardiac surgeons, increase guideline adherence in decision making for myocardial revascularization. Ultimately the study project aims to improve patient care in terms of decision making for appropriate myocardial revascularization. Through the consistent implementation of the German National Care Guideline on chronic Coronary Artery Disease (NVL-cKHK) and the European Guidelines on myocardial revascularization, the reduction of morbidity, mortality and the reduced need for subsequent revascularization procedures are also desirable from a health economics perspective.

Keywords

coronary heart disease - coronary artery disease - quality assurance - health care research - heart team - guidelines

Full Text

References

References
1 German Medical Association (BÄK), National Association of Statutory Health Insurance Physicians (KBV), Association of Scientific Medical Societies (AWMF). National Care Guideline Chronic CHD. Accessed January 20, 2020 at: https://www.leitlinien.de/nvl/khk
2 Neumann FJ, Sousa-Uva M, Ahlsson A. et al; ESC Scientific Document Group. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J 2019; 40 (02) 87-165
3 Neumann FJ, Byrne RA, Sibbing D. et al. Kommentar zu den „2018 ESC/EACTS Guidelines on Myocardial Revascularization“ der European Society of Cardiology (ESC) und der European Association for Cardio-Thoracic Surgery (EACTS). Kardiologe 2019; 13: 181-192
4 Federal Quality Report 2019 / Berlin: IQTIQ - Institute for Quality Assurance and Transparency in Health Care; 2020 Jan. Accessed on September 28, 2020 at: https://iqtig.org/qs-berichte/bundesqualitaetsbericht
5 The German Heart Report 2019. Frankfurt am Main. 2019 Accessed on November 21, 2020 at: http://www.herzstiftung.de/herzbericht
6 Beckmann A, Meyer R, Lewandowski J, Markewitz A, Gummert J. German Heart Surgery Report 2019: the annual updated registry of the German Society for Thoracic and Cardiovascular Surgery. Thorac Cardiovasc Surg 2020; 68 (04) 263-276
7 Federal health reporting. Surgeries and procedures of inpatients in hospitals (place of residence/place of treatment). Classification features: Years, region, age, sex. Accessed November 21, 2020 at: http://www.gbe-bund.de/oowa921-install/servlet/oowa/aw92/dboowasys921.xwdevkit/xwd_init?gbe.isgbetol/xs_start_neu/&p_aid=i&p_aid=81831931&nummer=662&p_sprache=D&p_indsp=-&p_aid=13786543
8 Sianos G, Morel M-A, Kappetein AP. et al. The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease. EuroIntervention 2005; 1 (02) 219-227
9 Swart E, Gothe H, Geyer S. et al; German Society for Social Medicine and Prevention, German Society for Epidemiology. Good practice secondary data analysis (GPS): guidelines and recommendations. Gesundheitswesen 2015; 77 (02) 120-126
10 Swart E, Bitzer E, Gothe H. et al. A consensus German reporting standard for secondary data analyses, version 2. Gesundheitswesen 2016; 78 (S 01): e145-e160
11 Working Group on Collection and Use of Secondary Data (AGENS). GPS—Good Practice in Secondary Data Analysis: Revision after Fundamental Reworking. Accessed on September 28, 2020 from: https://www.dgepi.de/assets/Leitlinien-und-Empfehlungen/Practice-in-Secondary-Data-Analysis.pdf
12 Long J, Luckraz H, Thekkudan J, Maher A, Norell M. Heart team discussion in managing patients with coronary artery disease: outcome and reproducibility. Interact Cardiovasc Thorac Surg 2012; 14 (05) 594-598
13 Chu D, Anastacio MM, Mulukutla SR. et al. Safety and efficacy of implementing a multidisciplinary heart team approach for revascularization in patients with complex coronary artery disease: an observational cohort pilot study. JAMA Surg 2014; 149 (11) 1109-1112
14 Bonzel T, Schächinger V, Dörge H. Description of a heart team approach to coronary revascularization and its beneficial long-term effect on clinical events after PCI. Clin Res Cardiol 2016; 105 (05) 388-400
15 Pavlidis AN, Perera D, Karamasis GV. et al. Implementation and consistency of Heart Team decision-making in complex coronary revascularisation. Int J Cardiol 2016; 206: 37-41
16 Sanchez CE, Dota A, Badhwar V. et al. Revascularization heart team recommendations as an adjunct to appropriate use criteria for coronary revascularization in patients with complex coronary artery disease. Catheter Cardiovasc Interv 2016; 88 (04) E103-E112
17 Domingues CT, Milojevic M, Thuijs DJFM. et al. Heart Team decision making and long-term outcomes for 1000 consecutive cases of coronary artery disease. Interact Cardiovasc Thorac Surg 2019; 28 (02) 206-213
18 Scholl I, Kriston L, Härter M. PEF-FB-9–Fragebogen zur Partizipativen Entscheidungsfindung (revidierte 9-Item-Fassung). Klin Diagn Eval 2011; 4: 49
19 Spertus JA, Winder JA, Dewhurst TA. et al. Development and evaluation of the Seattle Angina Questionnaire: a new functional status measure for coronary artery disease. J Am Coll Cardiol 1995; 25 (02) 333-341
20 McNamara RL, Spatz ES, Kelley TA. et al. Standardized outcome measurement for patients with coronary artery disease: consensus from the International Consortium for Health Outcomes Measurement (ICHOM). J Am Heart Assoc 2015; 4 (5, e00s1767): e001767
21 Buchholz A, Hölzel L, Kriston L. et al. Die Decisional Conflict Scale in deutscher Sprache (DCS-D) – Dimensionale Struktur in einer Stichprobe von Hausarztpatienten. Klin Diagn Eval 2011; 4: 15-30
22 Berth H, Petrowski K, Balck F. Die Amsterdam Preoperative Anxiety and Information Scale (APAIS) - erste Erprobung einer deutschsprachigen Version. GMS Psycho-Social-Medicine. 2007: 4
23 Chan PS, Jones PG, Arnold SA, Spertus JA. Development and validation of a short version of the Seattle angina questionnaire. Circ Cardiovasc Qual Outcomes 2014; 7 (05) 640-647
24 Kroenke K, Spitzer RL, Williams JBW, Löwe B. An ultra-brief screening scale for anxiety and depression: the PHQ-4. Psychosomatics 2009; 50 (06) 613-621
25 Andersen HH, Mühlbacher A, Nübling M. Die SOEP-Version des SF 12 als Instrument gesundheitsökonomischer Analysen. 2007 ; ISSN: 1864–6689
26 Schulz U, Schwarzer R. Soziale Unterstützung bei der Krankheitsbewältigung: Die Berliner Social Support Skalen (BSSS). Diagnostica 2003; 49: 73-82
27 World Medical Association. WMA Declaration of Helsinki - Ethical Principles for Medical Research Involving Human Subjects. Accessed on September 28, 2020 from: https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/
28 Cohen DJ, Osnabrugge RL, Magnuson EA. et al; SYNTAX Trial Investigators. Cost-effectiveness of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with 3-vessel or left main coronary artery disease: final results from the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) trial. Circulation 2014; 130 (14) 1146-1157
29 Magnuson EA, Farkouh ME, Fuster V. et al; FREEDOM Trial Investigators. Cost-effectiveness of percutaneous coronary intervention with drug eluting stents versus bypass surgery for patients with diabetes mellitus and multivessel coronary artery disease: results from the FREEDOM trial. Circulation 2013; 127 (07) 820-831
30 Tam DY, Dharma C, Rocha R. et al. Long-term survival after surgical or percutaneous revascularization in patients with diabetes and multivessel coronary disease. J Am Coll Cardiol 2020; 76 (10) 1153-1164